UASt regulatory sequences drive expression of an inverted repeat.
Scer\GAL4Cg.PA SPARCGD5660 larvae fail to pupate, with some arresting as 3rd instars for up to 10 days. In contrast to wild type, only about half of these mutant larvae are feeding at any one time.
Fat body from Scer\GAL4Cg.PA SPARCGD5660 3rd instar larvae shows a mild disruption of tissue morphology - adipocytes are rounded and membranes bleb. Whereas wild type adipocytes are polygonal, these mutant adipocytes are spherical with an increased number of surface pits. TEM shows that these cells have abnormal ribosome-enriched cytoplasm with a dramatic accumulation of fibrous ECM at cell boundaries - the basal lamina juxtaposed to the adipocytes is fibrous and highly variable in thickness.
Adults expressing SPARCGD5660 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Clonal activation of BM-40-SPARCGD5660 using Scer\GAL4αTub84B.PP does not affect the survival of the BM-40-SPARCGD5660-expressing cells surrounded by wild-type cells.
Expression under the control of Scer\GAL4Mef2.PR results in early larval lethality.
Expression under the control of Scer\GAL4Mef2.PR results in grossly normal larval body wall muscles.
Expression under the control of Scer\GAL4Mef2.PR results in wild-type sarcomeres in the larval body wall muscles.
Scer\GAL4αTub84B.PBb/SPARCGD5660 is an enhancer of increased cell death | cell non-autonomous | somatic clone phenotype of MycαTub84B.PBb
SPARCGD5660/Scer\GAL4r4 is an enhancer of extracellular matrix | larval stage phenotype of Ncra\QFQF2.Act5C.PL, Ras85DV12.QUAS.cLa, scribQUAS.HMS01490
SPARCGD5660/Scer\GAL4r4 is an enhancer of muscle attachment site | larval stage phenotype of Ncra\QFQF2.Act5C.PL, Ras85DV12.QUAS.cLa, scribQUAS.HMS01490
SPARCGD5660/Scer\GAL4r4 is an enhancer of larval muscle system | larval stage phenotype of Ncra\QFQF2.Act5C.PL, Ras85DV12.QUAS.cLa, scribQUAS.HMS01490
When cell clones expressing Scer\GAL4αTub84B.PBb>BM-40-SPARCGD5660 are surrounded by dmαTub84B.PBb-expressing cells in the super-competitor assay, the majority of BM-40-SPARCGD5660-expressing cells are eliminated, and the clones are strongly reduced in size at 48 h after clone induction (ACI), whereas loser cells not expressing BM-40-SPARCGD5660 show this effect only at 72 h ACI.